Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · May 23, 2023

Risks Associated With Topical Carbonic Anhydrase Inhibitor Use in Patients With Glaucoma and Chronic Kidney Disease

American Journal of Ophthalmology


Additional Info

American Journal of Ophthalmology
Risks of Topical Carbonic Anhydrase Inhibitors in Glaucoma Patients with Chronic Kidney Disease: A Nationwide Population-Based Study
Am J Ophthalmol 2023 May 04;[EPub Ahead of Print], YC Wang, XC Ling, WH Tsai, JS Liu, KL Kuo

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading